Currrax Pharmaceuticals over-performed its 2024 revenue goal and has exceeded 50% year-over-year revenue growth for its ...
Pyridostigmine bromide extended-release tablets: Alvogen and Rising Pharmaceuticals have both reported shortages of pyridostigmine bromide 180-milligram, extended-release tablets. Rising estimated ...
The 200-acre Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers, including engineers, ...
Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...
A crucial challenge in AI today is bridging the gap between general intelligence and deep, organisation-specific knowledge.
In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...
Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...
Lounge access, elite status and a slew of available travel and business credits make this card quite valuable — if you’ll use all of those perks. If not, the annual fee isn’t worth it.
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered nearly 70 lawsuits be coordinated beefore U.S.
Alembic reported a 163% surge in consolidated net profit to Rs 26.09 crore, on a 47.3% jump in revenue from operations to Rs 57.92 crore in Q3 FY25 over Q3 FY24.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback